Independent Director · Celldex Therapeutics, Inc. (CLDX)

Chair, Science and Commercialization Committee

Cheryl L. Cohen director compensation at Celldex Therapeutics: $282K

Fiscal year 2025 director compensation for Cheryl L. Cohen at Celldex Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Cheryl L. Cohen’s full pay file as a PDF — free

More than this page: up to 10 years of Cheryl’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Cheryl L. Cohen and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Celldex Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Celldex Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$60,431$0$221,517$0$281,948
FY2024$58,340$0$434,709$0$493,049
FY2023$46,417$0$320,602$0$367,019

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Celldex Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001104659-26-050884, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Celldex Therapeutics, Inc. filed document, accession 0001104659-26-050884. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Celldex Therapeutics Board Governance Report

$281,948 Cheryl L. Cohen, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Celldex Therapeutics pays directors a $48,000 cash retainer and $221,517 in Stock Options.

Committees

FY2025 · as the proxy prints them

Compensation · Science and Commercialization (Chair)

The rest of the Celldex Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Anthony S. MarucciDirector—
Denice TorresIndependent Director$480,451
Garry A. Neil, M.DIndependent Director$284,445
Harry H. Penner, JrChair of the Board$296,939
Herbert J. ConradIndependent Director$279,451
James J. MarinoIndependent Director$294,434
Keith L. BrownlieIndependent Director$289,439
Rita I. Jain, M.DIndependent Director$279,451

The full Celldex Therapeutics compensation record

free company brief

This page is one director within Celldex Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Celldex Therapeutics proxy · each links to its own free brief

Order CLDX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report